Meta Pixel

News and Announcements

Live Fantasy Sport App Ballr Announce Partnership with UBER in Indonesia

  • Published February 22, 2017 3:44PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Ballr, the free gaming platform for fans to connect, compete and communicate during real-time sporting events today announced a partnership with Uber Indonesia.

During a live football match, Ballr captures real-time data related to thousands of micro moments, such as a pass, tackle, shot, foul, assist, goal. Ballr converts each discreet event into a points value. This forms the basis of a video game people can play on their smartphone against millions of other fans in real time. Game winners receive epic experiences and prizes. This will now include free rides with Uber.

Sam Jones, Ballr Founder and CEO commented, “We are thrilled to be announcing this partnership with Uber, the ultimate consumer app. Indonesia is a major focus for us, where smartphone penetration is exploding and football is the national sport.”

As part of the partnership, Uber, will provide game prizes including vouchers to ride in their very best cars.

The app launches in Asia in February 2017 covering all EPL fixtures. Other major leagues will be added in 2017 including La Liga Santander, Serie A, CSL and A League.

 

Capital Insights
The control layer for the electrified home

THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Join over 45,000+ sophisticated investors

Join Now